STONE HEISZ LESLIE 4
4 · Edwards Lifesciences Corp · Filed Feb 13, 2025
Insider Transaction Report
Form 4
STONE HEISZ LESLIE
Director
Transactions
- Sale
Common Stock
2025-02-13$75.86/sh−5,739$435,371→ 30,035 total - Exercise/Conversion
Director Stock Option (Right to Acquire)
2025-02-13−5,739→ 0 totalExercise: $45.32From: 2018-05-18Exp: 2025-05-17→ Common Stock (5,739 underlying) - Exercise/Conversion
Common Stock
2025-02-13$45.32/sh+5,739$260,073→ 35,774 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $75.42 to $76.37. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.